Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Oral isotretinoin effectively treated the man's painful scalp condition and hair loss.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Acitretin effectively treats severe hypertrophic lichen planus.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Etanercept effectively treated a severe skin condition when other treatments failed.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Upadacitinib effectively treats severe alopecia areata and is safe.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.